Abstract 3893: Obinutuzumab (GA101) Versus Rituximab Against Rituximab-Sensitive and -Resistant Burkitt Lymphoma (BL) Differentially Phosphorylate BCR, Fc-gamma Receptor, and Natural Killer Cell-Mediated Cytotoxicity Signaling Pathways
Cancer research(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要